Blog

International Stem Cell: Seeking A Better Treatment For Parkinson’s – Investing.com


Investing.com

International Stem Cell: Seeking A Better Treatment For Parkinson's
Investing.com
International Stem Cell Corp (OTC:ISCO) is an early-stage cell therapy company currently in Phase I/IIa clinical trials to treat Parkinson's disease (PD). In addition, ISCO sells skincare and biomedical supplies to the market, generating $8m in sales

2016-05-16 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.